NeuroBio
  • Home
  • About Us
    • Our Science
    • Our Pipeline
    • Neuro-Bio Assets
  • Our People
    • Board
    • Management
    • Science Team
    • Science Advisory Board
    • Company Organogram
  • Publications
  • Investors
    • Hear from our Investors
    • FAQ’s
  • News
    • Supporters
  • Work With Us
    • Careers
    • Industrial Placements
  • Contact
Select Page

Neuro-Bio at the Rosalind Franklin institute.

Great success for Neuro-bio’s CEO, Susan Greenfield at the Rosalind Franklin Institute on Thursday 27.01.

She talked about the assets that the company is currently working on and had the chance to talk and meet the audience.

The Neuro-bio’s team was there to support as well.

LATEST NEWS

  • Neuro-Bio’s first paper of 2026 has been published!
  • Jo Hayman from Rathbones (UK-based investment and wealth management company) visits Neuro-Bio!
  • CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures
  • CEO & Founder Baroness Susan Greenfield visits San Raffaele Hospital in Milan!
  • Neuro-Bio featured in Corriere Salute – a health & wellbeing section of Corriere della Sera, one of Italy’s most established and widely read national newspapers!

TOPICS

  • Latest News
  • Media

© Neuro-Bio 2025

  • Instagram
© Neuro-Bio 2025